AIM: Clinician-reported outcome instruments such as the North Star Ambulatory Assessment (NSAA) need to be able to detect clinically important change to be suitable for clinical trials. However, in Duchenne muscular dystrophy (DMD), identifying changes in function is not straightforward. In this study, we use Rasch-transformed data to examine the responsiveness and minimal important difference (MID) of the NSAA in males with DMD receiving different corticosteroid regimes. METHOD: NSAA data were examined from 198 males (mean age at assessment was 8 y 6 mo [SD 2 y 6 mo] range 4 y-18 y; 805 assessments). Responsiveness was assessed using mean score changes (using Rasch-transformed data) between adjacent pairs of age groups, pairwise squared t-values from paired samples t-tests, and an effect size calculation. The MID was assessed using the effect size calculation and 0.5 standard deviation (SD) of mean score differences. RESULTS: Our findings revealed a difference in change scores over time between the two corticosteroid regimes. Mean NSAA person estimates were higher in the daily prednisolone group. The mean MID (0.5 SD) was 8.8 and 6.9 for the daily group and intermittent group respectively. INTERPRETATION: This study, based on Rasch-transformed NSAA data, provides an initial basis for the interpretation of clinical change in DMD over time and between corticosteroid regimes. Our proposed MIDs can be mapped back to differences in specific item content across the range of the NSAA.
AIM: Clinician-reported outcome instruments such as the North Star Ambulatory Assessment (NSAA) need to be able to detect clinically important change to be suitable for clinical trials. However, in Duchenne muscular dystrophy (DMD), identifying changes in function is not straightforward. In this study, we use Rasch-transformed data to examine the responsiveness and minimal important difference (MID) of the NSAA in males with DMD receiving different corticosteroid regimes. METHOD: NSAA data were examined from 198 males (mean age at assessment was 8 y 6 mo [SD 2 y 6 mo] range 4 y-18 y; 805 assessments). Responsiveness was assessed using mean score changes (using Rasch-transformed data) between adjacent pairs of age groups, pairwise squared t-values from paired samples t-tests, and an effect size calculation. The MID was assessed using the effect size calculation and 0.5 standard deviation (SD) of mean score differences. RESULTS: Our findings revealed a difference in change scores over time between the two corticosteroid regimes. Mean NSAA person estimates were higher in the daily prednisolone group. The mean MID (0.5 SD) was 8.8 and 6.9 for the daily group and intermittent group respectively. INTERPRETATION: This study, based on Rasch-transformed NSAA data, provides an initial basis for the interpretation of clinical change in DMD over time and between corticosteroid regimes. Our proposed MIDs can be mapped back to differences in specific item content across the range of the NSAA.
Authors: David J Birnkrant; Katharine Bushby; Carla M Bann; Susan D Apkon; Angela Blackwell; David Brumbaugh; Laura E Case; Paula R Clemens; Stasia Hadjiyannakis; Shree Pandya; Natalie Street; Jean Tomezsko; Kathryn R Wagner; Leanne M Ward; David R Weber Journal: Lancet Neurol Date: 2018-02-03 Impact factor: 44.182
Authors: Sarah P Sherlock; Jeffrey Palmer; Kathryn R Wagner; Hoda Z Abdel-Hamid; Enrico Bertini; Cuixia Tian; Jean K Mah; Anna Kostera-Pruszczyk; Francesco Muntoni; Michela Guglieri; John F Brandsema; Eugenio Mercuri; Russell J Butterfield; Craig M McDonald; Lawrence Charnas; Shannon Marraffino Journal: J Neurol Date: 2022-04-08 Impact factor: 6.682
Authors: Daniel Hind; James Parkin; Victoria Whitworth; Saleema Rex; Tracey Young; Lisa Hampson; Jennie Sheehan; Chin Maguire; Hannah Cantrill; Elaine Scott; Heather Epps; Marion Main; Michelle Geary; Heather McMurchie; Lindsey Pallant; Daniel Woods; Jennifer Freeman; Ellen Lee; Michelle Eagle; Tracey Willis; Francesco Muntoni; Peter Baxter Journal: Pilot Feasibility Stud Date: 2017-03-27
Authors: Sean C Forbes; Rebecca J Willcocks; William T Triplett; William D Rooney; Donovan J Lott; Dah-Jyuu Wang; Jim Pollaro; Claudia R Senesac; Michael J Daniels; Richard S Finkel; Barry S Russman; Barry J Byrne; Erika L Finanger; Gihan I Tennekoon; Glenn A Walter; H Lee Sweeney; Krista Vandenborne Journal: PLoS One Date: 2014-09-09 Impact factor: 3.240
Authors: L Jensen; S J Petersson; N O Illum; H C Laugaard-Jacobsen; T Thelle; L H Jørgensen; H D Schrøder Journal: J Musculoskelet Neuronal Interact Date: 2017-06-01 Impact factor: 2.041
Authors: Ronald G Victor; H Lee Sweeney; Richard Finkel; Craig M McDonald; Barry Byrne; Michelle Eagle; Nathalie Goemans; Krista Vandenborne; Alberto L Dubrovsky; Haluk Topaloglu; M Carrie Miceli; Pat Furlong; John Landry; Robert Elashoff; David Cox Journal: Neurology Date: 2017-09-29 Impact factor: 9.910